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Research and screening of anxiety in the perinatal period is hampered by a lack of psychometric data 
on self-report anxiety measures used in perinatal populations. This paper aimed to review self-report 
measures that have been validated with perinatal women. 
Methods 
A systematic search was carried out of four electronic databases. Additional papers were obtained 
through searching identified articles. Thirty studies were identified that reported validation of an 
anxiety measure with perinatal women. 
Results 
Most commonly validated self-report measures were the General Health Questionnaire (GHQ), State 
Trait Anxiety Inventory (STAI), and Hospital Anxiety and Depression Scales (HADS). Of the 30 
studies included, 11 used a clinical interview to provide criterion validity. Remaining studies reported 
one or more other forms of validity (factorial, discriminant, concurrent and predictive) or reliability.  
The STAI shows criterion, discriminant and predictive validity and may be most useful for research 
purposes as a specific measure of anxiety. The Kessler 10 (K-10) may be the best short screening 
measure due to its ability to differentiate anxiety disorders. The Depression Anxiety Stress Scales 21 
(DASS-21) measures multiple types of distress, shows appropriate content, and remains to be 
validated against clinical interview in perinatal populations.  
Limitations 
Nineteen studies did not report sensitivity or specificity data. The early stages of research into 
perinatal anxiety, the multitude of measures in use, and methodological differences restrict 
comparison of measures across studies. 
Conclusion 
There is a need for further validation of self-report measures of anxiety in the perinatal period to 
enable accurate screening and detection of anxiety symptoms and disorders. 
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Introduction 
Anxiety symptoms and disorders are an important area of research in perinatal populations (Matthey 
et al., 2003; Ross et al., 2003). Symptoms of anxiety are common in the perinatal period. In a UK 
study of 8,323 women, 13% of women reported anxiety symptoms at either eight weeks or eight 
months postpartum and of these two-thirds had experienced anxiety in pregnancy (Heron et al., 2004). 
A prospective study of 1,507 women expecting their first child found 8.5% of women reported intense 
anxiety or panic attacks occasionally or often between 6 and 9 months postpartum in a computer 
assisted telephone interview (Woolhouse et al., 2009). A study using diagnostic interviews with 
women eight weeks postpartum found 8.2% of women had generalized anxiety disorder (GAD), 2.7% 
had obsessive compulsive disorder (OCD), 1.4% had panic disorder and 4.1% social anxiety disorder  
(Wenzel et al., 2005). A further 19.7% of women had sub-syndromal GAD, 5.4% sub-syndromal 
OCD and 15% sub-syndromal social anxiety. GAD was more prevalent in postpartum women than in 
the general population, OCD and panic disorder were as prevalent as in the general population, whilst 
social anxiety was less common in postpartum women (Wenzel et al., 2005). 
Although prevalence data of anxiety disorders is limited, a review tentatively suggests that rates of 
OCD and GAD are higher in perinatal populations than in the general population, whilst rates of panic 
disorder and posttraumatic stress disorder (PTSD) are comparable (Ross and McLean, 2006). There is 
also preliminary evidence that a further proportion of women experience clinically significant anxiety 
symptoms that do not fit into DSM-IV anxiety diagnoses (Phillips et al., 2009). In a sample of women 
with unsettled infants, equal numbers of women were diagnosed by clinical interview with an anxiety 
disorder not otherwise specified (ADNOS; 10.8%) as were diagnosed with GAD (10.8%) (Phillips et 
al., 2009). None of the women diagnosed with ADNOS had primary symptoms related to OCD, social 
anxiety, specific phobias or panic disorder indicating that anxiety disorders in postnatal women may 
not be optimally defined. Furthermore, the occurrence of pregnancy-specific anxiety that needs to be 
treated as a relatively distinct syndrome has been proposed (Huizink et al., 2004). State anxiety 
explains a small part of important fears of giving birth, having a disabled child, and concerns about a 
woman’s appearance when she is pregnant (Huizink et al., 2004). Pregnancy specific stress has 
predicted poor birth outcomes better than state anxiety and perceived stress (Lobel et al., 2008). Thus 
in both antenatal and postnatal women, general measures of anxiety may not be appropriate screening 
tools. 
Anxiety disorders and subthreshold anxiety symptoms can be detrimental to the mother-infant 
relationship (Zelkowitz and Papageorgiou, 2005). Prenatal anxiety has been linked with intrauterine 
artery resistance leading to low birthweight (Teixeira et al., 2009; Field et al., 2010), low apgar scores 
(Berle et al., 2005),  suboptimal changes in fetal heart rate and motor activity (DiPietro, 2010) and  
complications of labour and delivery (Johnson and Slade, 2003). Longer term effects of high antenatal 
anxiety can include externalizing problems and self-reported anxiety at ages 8-9 (Van den Bergh and 
Marcoen, 2004) and high impulsivity and lower scores on cognitive tests at ages 14-15 (Van den 
Bergh et al., 2005).  History of an anxiety disorder before pregnancy is a greater risk factor for 
postnatal anxiety or depression than a history of depressive disorder (Matthey et al., 2003). 
Additionally, anxiety disorders during pregnancy predict postnatal depression symptoms independent 
of antenatal depression. One study shows that women with anxiety disorders in pregnancy are nearly 
three times more likely to present with postnatal depression (Sutter-Dallay et al., 2004). A large 
prospective study (n = 12,361) confirms that antenatal anxiety is one of the strongest predictors of 
postnatal depression indicating that antenatal screening for anxiety may be helpful in reaching women 
at risk of postnatal depression (Milgrom et al., 2008). A recent review indicates that postnatal 
maternal anxiety is associated with deleterious outcomes for children such as alterations in emotional 
and conduct problems, and adverse effects on cognitive and social developments, although effects on 
infant temperament are inconclusive (Glasheen et al., 2010).  
As in other clinical populations, there is substantial comorbidity between anxiety and depression in 
perinatal women. Studies using clinical interviews to diagnose disorders show that up to 50% of 
women with affective disorders have comorbid anxiety and depression. For example, a study of 
anxiety and depression at 36 weeks gestation, 6 weeks postpartum and 16 weeks postpartum found 
that nearly 50% of clinically depressed women experienced clinically significant comorbid anxiety 
(Ross et al., 2003). Depending on the domain of anxiety being considered, Wenzel et al. (2005) found 
that 10-50% of women reporting anxiety symptoms also endorsed depressive symptoms.  In two 
samples of women interviewed at 6 weeks postpartum Matthey et al. (2003) found 16.2% and 10.4% 
of women had anxiety disorders only, whereas 5.6% and 2.6% had major or minor depression only, 
and 4.2% and 2.1% had comorbid depression and anxiety highlighting the importance of screening for 
both depression and anxiety.. These studies all used clinical interviews to diagnose anxiety and 
depression.  
 Given the high prevalence (but also variation) of perinatal anxiety, it is important to identify valid 
questionnaire measures of anxiety that can be used in research and clinical practice. Two broad 
approaches can be taken: (i) to use measures of anxiety developed with other populations and validate 
them for use with perinatal women; or (ii) to develop specific measures of perinatal anxiety. Research 
and screening for perinatal depression has taken the latter approach, as illustrated by the Edinburgh 
Postnatal Depression Scale (EPDS; Cox et al., 1987) which is the most widely used screening tool 
used for postnatal depression (Boyd et al., 2005).  
The creation of the EPDS and other measures of depression specific to the perinatal period derived 
partly from the inappropriateness of general depression measures to perinatal women, largely because 
of the inclusion of items measuring somatic symptoms. Specific depression measures such as the 
EPDS were therefore developed and validated for use in the perinatal period. However, the utility of 
the EPDS appears to vary in different samples (Gibson et al., 2009) and there is evidence that the 
EPDS has three items that also measure anxiety. Some propose it therefore contains an unofficial 
anxiety subscale, but this only contains three items which is likely to be insufficient to capture the 
complexity of anxiety as a construct. Muzik et al. (2000) found that women with anxiety disorders 
had significantly lower scores on the EPDS than women with major depressive disorder. These 
women would therefore not be identified using only the EPDS. Thus, if the EPDS is the only measure 
used to screen perinatal women, it will be unclear whether the anxiety symptoms are features of 
depression or are a separate clinical entity (Ross et al., 2003). There is also evidence that the 
depression subscale of the EPDS correlates more highly with other measures of anxiety than the 
anxiety subscale does, indicating poor convergent validity (Brouwers et al., 2001). 
With the exception of measures of pregnancy-specific worries or anxiety, no specific measures of 
anxiety have been developed for use in perinatal populations. Most measures used were originally 
designed for use in generic samples. Validity of any self-report measure depends on recalibration for 
the population under study (Geisinger, 1994). Self-report measures constructed for use with one 
population may produce flawed results in another population because the distribution of the variable 
will differ according to a number of factors including culture, development and time of measurement 
in the perinatal period. Normative values and cut-offs may also vary in samples that differ from the 
original sample. Therefore an evaluation must be made as to whether the sample with whom the test 
was designed is sufficiently similar to the test sample to ensure little variability in functioning of the 
self-report measure (Myers and Winters, 2002). Self-report measures created for use in populations in 
western countries are often validated for use in different languages and cultures (Prince, 2008). 
However measures designed for use in general populations are not as frequently validated for use in 
perinatal populations despite the unique nature of this period. 
Research into perinatal anxiety uses a variety of self-report measures including the State Trait Anxiety 
Inventory (STAI; Spielberger et al., 1970), Crown-Crisp Experiential Index (Crisp et al., 1978) and 
Beck Anxiety Inventory (Beck et al., 1988). These general measures are rarely validated for use in 
perinatal populations which could lead to erroneous interpretation and incomparable data. A variety of 
different cut-off points on measures have also been used to indicate severe anxiety or disorder. For 
example the STAI has been used in perinatal samples with cut-offs of >40 (Grant et al., 2008) to >45 
(Moss et al., 2009) or >48 (Field et al., 2010) to indicate disorder, without prior validation in this 
population. 
In sum, there is as yet no measure specifically devised to screen for anxiety disorders or symptoms in 
perinatal populations. Psychometrically robust measures of anxiety are needed for screening and 
research purposes. This paper therefore aims to systematically identify and review measures of 




A systematic search of the following computerised databases was undertaken: SCOPUS V.4 
(Elsevier), MEDLINE (CSA), PsycINFO (CSA) and the Cumulative Index to Nursing and Allied 
Health Literature (CINAHL) for the time period from inception of the database to 30 September 2010. 
The following search terms were used to search all databases:  anx*, pregnan* or *natal or *partum, 
diagnos* or screen or questionnaire or tool or scale. In addition the reference lists of included papers 
were searched.  
Inclusion / exclusion criteria 
Inclusion criteria were that published studies i) were written in English; ii) examined the reliability 
and/or validity of a self-report anxiety measure; iii) the sample were antenatal or postnatal women (up 
to one year postpartum). A number of studies validated more than one measure on the same sample 
resulting in more than one publication. These papers are included with a note indicating the multiple 
use of the sample. To enable comparison, all measures were originally devised in English. 
Data quality 
Quality of studies was assessed using a combined checklist based on the quality assessment of 
diagnostic accuracy studies (QUADAS) (Whiting et al., 2003) and a checklist developed by Mirza 
and Jenkins (2004). Criteria were assessed as present or absent on 11 dimensions (range 0 – 11): 1) 
explicit study aims; 2) adequate sample size; 3) sample described in sufficient detail; 4) sample 
representative of population receiving test in practice; 5) clear inclusion and exclusion criteria; 6) use 
of appropriate reference standard; 7) reliability of measure reported 8) validity of measure 
investigated; 9) specification of dropouts and withdrawal of participants; 10) adequate description of 
data and, 11) discussion of generalisability. The studies were then given a total score of quality with 
the highest possible being eleven. Most studies were of good quality with 22 (73%) having a score of 
8 or more. Inter-rater reliability was checked for four (13%) studies and agreement across all 11 
dimensions for those studies was very high (mean agreement across studies was 97%). 
Validity 
Various types of validity data were extracted. Criterion validity is inferred by comparing the sample’s 
score on the index measure with a more objective measure of the same construct. Criterion validity 
should be established against an existing gold standard (Greenhalgh, 1997). For determining anxiety 
disorders, the gold standard is defined as a diagnostic clinical interview (Gibson et al., 2009). Validity 
is inferred by a measure correctly identifying most people with the disorder (high sensitivity) and 
correctly excluding most people without the disorder (high specificity). In line with a review of 
measures to detect postnatal depression, the following criteria were applied to this type of 
psychometric data: >.90 as excellent, .90-.80 as good, .70-.50 as moderate, .50-.30 as low, and <.30 as 
poor (Boyd et al., 2005). Overall misclassification rate is the proportion of people incorrectly 
diagnosed. 
Available data were also extracted for concurrent validity, the ability of a test to correlate positively 
with measures of the same construct or negatively with measures of an opposing construct. Cohen’s 
(1992) criteria were used to evaluate effect size: r = 0.1, small; r = 0.3, medium; r =0.5, large. 
Discriminant validity (the ability of the measure to discriminate between groups differing in levels of 
anxiety) and factorial validity (the ability of the construct to provide a clear factor structure) was also 
extracted. 
Reliability 
The reliability of measures was evaluated by examining internal consistency and test-retest reliability. 
Internal consistency represents the extent to which different items of the same construct are scored 
similarly. For a scale to be reliable a minimum Cronbach’s alpha coefficient of 0.70 is recommended 
(Kline, 2000). Reliability is a measure of the properties of a test within a particular sample rather than 
a property of a test per se and therefore should be computed in each sample (Vacha-Haase et al., 
2000).  Test-retest reliability (the ability of a test to yield consistent scores over time) should be 
greater than .80 over one to two weeks or .70 or greater over one month (Boyd et al., 2005). As it is 
expected that anxiety levels fluctuate throughout pregnancy and the postpartum, test-retest reliability 
is only relevant to trait anxiety which should remain stable over time (Spielberger et al., 1970). 
 
Results 
Methods of validation and assessment of reliability 
Thirty studies were included. Studies often reported more than one type of validity. One study 
(Aboidun, 1994) validated two measures. Eleven studies (37%) used clinical interviews for criterion 
validity; 10 (33%) reported concurrent validity; 9 (30%) reported discriminant validity and 8 (27%) 
reported factorial validity. Three studies (10%) reported the validity of different scoring methods of a 
measure. Eleven studies (37%) reported internal consistency and two studies (7%) reported test-retest 
reliability. Eighteen studies (60%) did not report any reliability data. The heterogeneity of the studies 
and types of validity reported precluded any scope for meta-analysis in this review. An overview of 
included studies is given in Table 1. 
- Insert Table 1 about here - 
Self-report measures 
Thirteen studies validated the General Health Questionnaire (GHQ), five studies validated the State-
Trait Anxiety Inventory (STAI) and three studies validated the Hospital Anxiety and Depression 
Scales (HADS). A further nine studies reported a different measure each. Following is a description of 
each measure, a summary of reported validity and reliability, and an indication of its utility in 
perinatal samples.  
Hospital Anxiety and Depression Scales – Anxiety subscale (HADS-A) 
The HADS (Zigmond and Snaith, 1983) consists of an anxiety subscale (HADS-A) and a depression 
subscale (HADS-D), each comprising seven items to assess presence or absence of symptoms over the 
last week, on a four-point scale (0-3). Scores of 0-7 are considered ‘normal,’ 8-10 is considered 
suggestive of disorder, and 11+ indicates probable presence of a mood disorder (Snaith, 2003). A cut-
off of 8 has optimal sensitivity and specificity in non-perinatal samples (Bjelland et al., 2002). The 
scale was designed to include minimal reference to somatic symptoms (Snaith, 2003). A number of 
items on the HADS-A scale may have a different relevance to pregnant or postpartum women 
compared with other populations. For example ‘I can sit at ease and feel relaxed’ may be less likely in 
pregnant and postpartum populations.  
Three studies assessed the validity of the HADS-A throughout pregnancy using the recommended cut-
off of 8 to indicate possible anxiety disorders. No studies assessed the HADS-A in the postpartum. 
Only one study (Abiodun, 1994) reported validity coefficients. Sensitivity and specificity were 
particularly high (92.9% and 90.0%) and the misclassification rate was low (9.6%). This cut-off led to 
a high prevalence of possible cases of anxiety in the UK (36-56%) and Uzbekistani samples (38-42%) 
(Jomeen and Martin, 2004; Karimova and Martin, 2003) but low prevalence in Nigeria (5.8%; 
Abiodun, 1994). 
One study reported concurrent validity. The HADS-A correlated more highly with the EPDS (r = 
0.73) than with the HADS-D (r = 0.46) indicating a strong association with postnatal depression 
(Jomeen and Martin, 2004). Test-retest correlation between 12 and 34 weeks gestation and was low (r 
= 0.31) as may be expected over the course of pregnancy (Karimova and Martin, 2003).  Internal 
consistency across the studies ranged between 0.62 and 0.78 (Karimova and Martin, 2003; Jomeen 
and Martin, 2004).  
The factor structure of the HADS is unclear. In non-perinatal samples there is conflicting evidence of 
two, three or four factors (Bjelland et al., 2002). Two studies with perinatal women examined the 
factor structure of the HADS. Jomeen and Martin (2004) carried out principal components analysis 
(PCA) and confirmatory factor analysis (CFA). Both methods identified three factors: one anxiety (5 
items) and two depression factors, although two anxiety items did not load on the anxiety factor. 
These factors only accounted for around half of the variance in the scale, as indicated by the PCA 
(r2=.52) and fit indices of the CFA. Another study comparing the HADS structure for UK and 
Uzbekistani women at 12 and 34 weeks gestation found between two and five factors optimally fitted 
the data dependent on the time of gestation and nationality of group (Karimova and Martin, 2003).  
State Trait Anxiety Inventory (STAI) 
The STAI (Spielberger et al., 1970) consists of two subscales each with 20 items. The state subscale 
measures anxiety at this moment (related to a specific situation or time period). The trait subscale 
measures relatively stable individual propensity to respond with elevated anxiety i.e. as you generally 
feel. Respondents endorse items on a four-point scale (1-4). Some items such as ‘I tire quickly’ and ‘I 
feel rested’ may be confounded by pregnancy or postpartum factors. 
Six studies reported use of the STAI in perinatal populations. Two of these used the same sample 
(Barnett and Parker, 1985, 1986). One paper (Grant et al., 2008) reported validity coefficients. A cut-
off  >40 on both state and trait scales yielded optimal sensitivity (80.95%), specificity (79.75%), 
positive predictive value (51.50%) and negative predictive value (94.00%) to determine cases of 
anxiety in the third trimester of pregnancy. No studies have conducted a factor analysis on STAI in 
perinatal populations. Norms available from included studies are given in Table 2. 
Both the state and trait anxiety subscales are highly correlated with measures of depression. The 
subscales correlated more highly with the EPDS than with the BDI at 14 and 30 weeks postpartum. 
Correlations between the state subscale and a measure of anxiety (BAI) were similar to that observed 
with depression (Stuart et al., 1998).  
Barnett and Parker (1985, 1986) recommend cut-offs of high (≥ 40), moderate (32 - 33) or low (≤ 25) 
anxiety on the basis of mean trait scores of a sample of 94 primiparae (M =33.1, SD = 8.1; Barnett and 
Parker, 1985). Discriminant validity of these thresholds was shown by statistically significant 
differences in scores between groups on a number of self-report measures (Costello-Comrey trait 
anxiety and depression scales, Beck Depression Inventory, Eysenck Neuroticism Scale). More highly 
anxious women endorsed significantly more life events in the previous 12 months, and more distress 
associated with those life events, lower parental confidence and lower confidence in their maternal 
role (all ps <.05). Barnett and Parker (1986) reported further discriminant validity through inspection 
of hospital files where nursing staff considered a significantly higher percentage of women in the high 
anxiety group to have ‘mood problems’ than in the moderate or low anxiety groups. The interviewer, 
who was blind to group allocation, rated women with anxiety in the anticipated direction, but 
differences between groups were not significant. Interviewer ratings of increased arousal and 
unassertiveness also significantly differentiated between anxiety groups.  
Predictive validity of the STAI has been demonstrated in postnatal samples. A trait anxiety score of 
>40 was associated with a six-fold increase in postnatal anxiety disorders (odds ratio = 6.44, CI = 1.28 
- 32.28) and depression (odds ratio = 6.12, CI = 1.37 - 27.41) whilst antenatal state anxiety did not 
predict postnatal anxiety or depressive disorders (Grant et al., 2008). 
Test-retest reliability would be expected to be low for the state scale of the STAI, which should 
measure momentary fluctuations in anxiety, and high for the trait anxiety, which should remain stable. 
The latter is not the case in perinatal samples. Hundley et al (1998) found test-retest correlations of 
between 0.37 - 0.85 on the trait scale. In addition, women all had lower trait scores after birth than in 
pregnancy.  In Barnett and Parker’s (1985) sample, trait scores decreased by 2 - 10% between 3 days 
and 12 months postpartum. This has also been found in a Greek sample of mothers, 10.3% of whom 
had substantially lower trait scores at 3 months postpartum than at 2-3 days postpartum (Giakoumaki 
et al., 2009). In general, internal consistency is good, ranging from 0.91 – 0.95 for the state subscale 
of the full version (Marteau and Bekker, 1992; Grant et al., 2008) and 0.82 for the 6 item version 
(Marteau and Bekker, 1992). Reported trait scale internal consistency was 0.96 (Grant et al., 2008). 
 
Six and four item versions of the state scale of the STAI have been constructed and validated for use 
in pregnant populations (Marteau and Bekker, 1992). Concurrent validity was demonstrated by pro-
rating scores from the shortened versions and statistically testing for differences between original and 
pro-rated scores. The shortest scale score that did not differ significantly to the pro-rated total score 
consisted of 6 items correlating >.90 with scores on the full scale.  
- insert Table 2 about here - 
General Health Questionnaire (GHQ) 
The GHQ (Goldberg, 1972) is a widely used measure of non-psychotic psychopathology, used to 
screen for cases requiring further psychiatric consultation. It asks how the respondent has felt 
recently. Answers are given on a four-point scale with higher scores indicating increased likelihood of 
disorder. The GHQ has four different versions (60-item, 30-item; 28-item and 12-item versions) and 
can be scored in four different ways (Likert scoring 0 – 3; modified Likert scoring  0-0-1-2; C-GHQ 
scoring  0-1-1-1 for negative items (indicating illness) and 0-0-1-1 for positive items (indicating 
health); or dichotomous 0-0-1-1 scoring to indicate healthy and ill responses).  The shorter versions of 
the GHQ do not result in greatly reduced sensitivity and specificity in non-perinatal populations 
(Ayers, 2001). Only the GHQ-28 has a specific anxiety subscale.  Thirteen studies evaluated versions 
of the GHQ in perinatal samples. None of these used the 60 item version. Validity coefficients are 
shown in Table 3. 
GHQ-30 
Seven studies (comprising four different samples) used the GHQ-30. The GHQ-30 is the most widely 
validated version in non-perinatal populations and yields an overall total score. The recommended 
cut-off for identifying cases of psychiatric disorder is 4/5 for GHQ scoring and 23/24 for Likert 
scoring (GL Assessment, 2010).Cut-offs used in perinatal studies ranged from 5 in a Nigerian sample 
(Abiodun, 1993) to 7/8 in a Japanese sample (Kitamura et al., 1989, 1994a, 1994b). Specificity ranged 
from 71 - 89% across studies. Sensitivity was mostly in the range of 77 - 83%. However a Japanese 
study in pregnancy and at different time points postpartum found no cut-off yielded satisfactory 
sensitivity (Kitamura et al., 1994a). In addition to validating the GHQ-30, Nott and Cutts (1982) 
reported validity coefficients for a moderated version with two items that may be confounded by 
perinatal circumstances removed. The modified version increased specificity and decreased overall 
misclassification. 
Two studies performed discriminant function analyses. Kitamura et al (1989) showed that only 13 out 
of 30 items significantly contributed to the power of the measure to differentiate cases from non-
cases. Items that did not discriminate included: ‘Have you been getting out the house as much as 
usual’; ‘Have you been managing to keep yourself busy and occupied’ and ‘Have you spent much 
time chatting to people’. However Nott and Cutts (1982) found that 28 out of 30 items were related to 
‘caseness’. Their discriminant function analysis resulted in a combination of 12 items which if used 
together resulted in high sensitivity (98%) but low specificity (68%) and a high misclassification rate 
(27%).  
The GHQ scoring method provided the greatest discriminatory power between cases on the GHQ-30 
(Kitamura et al., 1993). 
GHQ-28 
Three studies validated the GHQ-28. The GHQ-28 (Goldberg and Hillier, 1979) contains four 
subscales measuring depression, somatic symptoms, anxiety/insomnia and social dysfunction. The 
factors do not have individual cut-off scores and caseness is determined from an overall score. 
Sensitivity and specificity ranged from 75 - 85% and were in keeping with a large study (n=5438) 
which also showed that cut-off points differed depending on culture and geographical locations 
(Goldberg et al., 1997). Across all studies sensitivity and specificity for all scoring methods were 
within 75 - 85% which is comparable with the overall sensitivity (79.7%) and specificity (79.2%) in 
Goldberg et al. (1997). Positive predictive value ranged from 46 - 53% (Aderibigbe and Gureje, 
1992). 
Correlations between the somatic symptom scale and clinical interview scores and between the 
anxiety subscale and clinical scores were significant but low (rs = 0.26 to 0.29; Aderibigbe and 
Gureje, 1992). Social dysfunction and depression subscales did not correlate significantly (Aderibigbe 
and Gureje, 1992). Discriminant function analysis of the subscales showed that the social dysfunction 
subscale did not make a significant contribution to the GHQ-28’s ability to discriminate cases from 
non-cases (Aderibigbe and Gureje, 1992). 
The factor structure of the GHQ-28 in an antenatal Nigerian population (Aderibigbe et al., 1996) 
differed to that found in UK primary care populations (Goldberg, 1979) although it is unclear whether 
this is due to cultural differences, the experience of pregnancy, or an interaction between the two. In 
the Nigerian sample, principal components analysis resulted in four factors explaining 40.1% of the 
variance in the data. Social dysfunction accounted for most variance (19%). Anxiety items were 
hypothesised to load onto a single factor but were divided between somatic-anxiety (9.7% of 
variance) and depression-anxiety (6.3% of variance) subscales. Severe depression accounted for 5.1% 
of the variance (Aderibigbe et al., 1996).  
Two studies considered scoring methods of the GHQ in perinatal samples. One study found that the 
C-GHQ method of scoring resulted in higher sensitivity and specificity than the standard GHQ 
scoring in Nigerian women in the late second or early third trimester (Aderibigbe and Gureje, 1992). 
The other study of a UK sample in the late first trimester suggested that the number of cases identified 
depended on the scoring method used with the standardized cut-off of 4/5 classifying more women as 
cases than the Likert scoring (Swallow et al., 2003).  
GHQ-12 
Three studies validated the GHQ-12 in perinatal samples. The GHQ-12 was compiled by removing 
items from the GHQ-60 that relate to physical symptoms and then selecting equal numbers of health 
present and health absent items that discriminate well between cases. The GHQ-12 has the advantage 
of being free of somatic symptoms, although it cannot distinguish between mood states as it gives a 
total score only and is not divided into subscales. It is quick to administer (approximately two 
minutes) and sensitivity and specificity for anxiety disorders were good in antenatal and postnatal 
populations in the two studies examining this (>0.80). The standardized threshold to indicate a case is 
1/2 for GHQ scoring and 11/12 for Likert scoring (GL Assessment, 2010). Cut-off scores had to be 
increased from the suggested standardized thresholds in order to obtain satisfactory validity 
coefficients. After birth, the GHQ-12 detected 69.6% of pure anxiety cases and 86.9% of depression 
with or without comorbid anxiety using a cut-off of 4/5 (Navarro et al., 2007). Post-hoc tests showed 
that the GHQ-12 found significant differences in scores between cases and non-cases, but did not find 
differences between diagnostic groups of anxiety, depression, comorbid anxiety and depression, or 
adjustment disorder.  
The EPDS and GHQ-12 showed good concurrent validity (r = 0.80) (Navarro et al., 2007). An effect 
of scoring method on case identification was found with the GHQ-12 (Martin and Jomeen, 2003). 
GHQ scoring resulted in 34.5% cases, C-GHQ scoring in 52.7% cases and Likert scoring in 45.5% of 
cases. The scores from the C-GHQ method resulted in significant main and interaction effects in an 
analysis of variance (ANOVA) but no effects were found with the Likert and GHQ methods in this 
sample of women with pre-labour rupture of membrane at term (Martin and Jomeen, 2003). The 
difference in number of cases identified and interpretation of ANOVA results depending on scoring 
method raises concerns about the reliability of the GHQ-12 in late pregnancy/early postpartum or at 
least highlights that scoring methods need to be validated against clinical interviews in this 
population. Internal consistency ranged from 0.81 - 0.95 (Martin and Jomeen, 2003). Validity 
coefficients are shown in Table 3. Only one paper reported normative data (Navarro et al., 2007).  
- insert Table 3 about here - 
Other measures 
The Personal Disturbance Scale (DSSI/sAD; Bedford and Foulds, 1978) is a 12-item self-report 
measure of anxiety and depression. One study validated the DSSI/sAD against a clinical interview at 
four time points in pregnancy and postpartum (Cox and O’Connor, 1983). This study found that the 
standardized cut-off point of 6 was not appropriate for pregnant women: 13 women out of 230 scored 
≥6 and of these only three had clinically significant psychiatric illness but not anxiety or depression. 
The scale did not identify two women with phobic neuroses. Increases in anxiety and depression at the 
first postpartum time point which were detected by clinical interview and visual analogue scales were 
not identified by the DSSI/sAD (Cox and O’Connor, 1983). Factor analysis in a non-perinatal 
population suggests the scale may be measuring one latent factor rather than two distinct anxiety and 
depression subscales (Shevlin et al., 1998).  
Two studies examined variations of the Symptom Checklist 90 Revised (SCL-90-R; Derogatis, 1992). 
The SCL-90-R comprises 90 items covering 9 primary dimensions including anxiety, phobic anxiety, 
somatisation, depression and obsessive compulsive scales, each measured on a five point scale. In a 
small sample of 3 or 6 month postpartum women the SCL-90-R anxiety subscale scores distinguished 
women with anxiety disorders from women with no psychiatric diagnosis but did not distinguish 
anxiety cases from depression cases in post-hoc tests  (Muzik et al., 2000). Women with major 
depressive disorder also had higher scores on the anxiety subscale than women with anxiety disorders 
although no women included in the analysis had comorbid anxiety and depression (Muzik et al., 
2000). 
The Hopkins-Symptom Checklist 25 (Derogatis et al., 1974) is a self-report inventory of 10 anxiety 
and 15 depression items derived from the SCL-90. A factor analysis in a large sample of pregnant 
HIV positive Tanzanian women yielded four factors representing depression-anxiety, anxiety, psycho-
physiological and physiological constructs rather than two clear factors (Kaaya et al., 2002). This 
effect could be due to pregnancy or diagnosis of HIV. Optimal cut-off points and validity coefficients 
were reported for detecting major depressive disorder only. The anxiety subscale showed good 
internal consistency (Cronbach’s alpha = 0.85).   
One study suggested that a single item ‘Do you feel very anxious?’ could be used to screen for 
anxiety in antenatal clinics where time is constrained (Sagrestano et al., 2001). This item correlated 
with standardized scores on the STAI showing a small to medium effect size (r = 0.24). Women who 
answered ‘yes’ to feeling anxious had significantly higher scores on the STAI than those who had 
answered no. The same situation was true for single items measuring depression and social support 
but single items measuring stress, relationship conflict, verbal abuse or violence from partner did not 
reliably differentiate between women experiencing high and low levels of these constructs. The 
questions were asked as part of an interview rather than a self-report questionnaire which may have 
influenced women’s decision to disclose such information (Sagrestano et al., 2001).  
The Pregnancy Anxiety Scale (PAS; Levin, 1991) is the only measure developed specifically for 
pregnant women. It measures pregnancy-specific anxiety with 13 yes/no items. Confirmatory factor 
analysis showed a clear structure of three latent factors measuring anxiety about being pregnant, 
anxiety about childbirth and anxiety about hospitalization with good model fit indices. However data 
about pregnancy anxiety was collected postpartum and no further studies have validated this measure. 
The Depression Anxiety Stress Scales (DASS; Lovibond and Lovibond, 1995) has three subscales 
designed to maximally discriminate between depression, anxiety and stress in the last week (Antony 
et al., 1998). The DASS excludes somatic items such as sleep disturbance, lack of energy and poor 
concentration which may not be valid markers for pregnant or postnatal women. The DASS is 
available in 42 or 21 item versions. The DASS-21 appears to measure anxiety without a large overlap 
with depression. In a study of 325 postnatal women, 240 women had EPDS scores <9 (a negative 
screen). Yet the DASS-21 identified eight of these women (3% of the total sample) as anxious and a 
further 10 women (4% of the total sample) as stressed. Internal consistency was acceptable for all 
subscales: 0.84, depression; 0.77, anxiety and 0.86, stress (Miller et al., 2006).  
The Kessler 10 (K-10; Kessler et al., 2002) is a short screening scale comprising 10 items designed to 
assess level of general psychological distress in the past four weeks. Scores can range from 10 (no 
distress) to 50 (severe distress). In a sample of women in early pregnancy the K-10 identified 69 - 
76% of diagnosed cases of anxiety disorders (Spies et al., 2009). Sensitivity ranged from 0.50 to 1.00 
and specificity from 0.75 - 0.98 dependent on the anxiety disorder in question. The scale performed 
best at detecting social anxiety disorder (sensitivity 1.00, specificity 0.98) but validity coefficients 
were lower for panic disorder (sensitivity 0.50, specificity 0.98) and PTSD (sensitivity 0.50, 
specificity 0.80). Numbers of women with anxiety disorders were low, limiting power to show 
representative sensitivity and specificity. However, the K-10 has shown robust psychometric 
properties in non-perinatal samples and had substantially better validity coefficients than the GHQ-12 
in discriminating cases of anxiety and mood disorders in the Australian National Survey of Mental 
Health and Well-being (Kessler et al., 2002; Furukawa et al., 2003).  A Dutch study improved the 
ability of the K10 to identify anxiety disorders by adding five further items pertaining to GAD, social 
anxiety disorder, panic and agoraphobia (Donker et al., 2010).  
Finally, two new measures have attempted to broaden the content of anxiety and psychological 
distress measures. Firstly, the Inventory of Depression and Anxiety Symptoms (IDAS; Watson et al., 
2007) is a new multi-dimensional measure of symptoms of anxiety and depression, containing 64 
items which yielded 10 factors in multiple samples relating to symptoms of: suicidality, lassitude 
(fatigue, lack of energy, hypersomnia), insomnia, appetite loss, appetite gain, ill temper, well-being, 
panic, social anxiety, and traumatic intrusions as well as two further scales assessing general 
depression scale and dysphoria. Responses refer to the previous two weeks and are scored on a scale 
from 0-3. In a large sample (n=832) of women less than 4 months postpartum, the 10 initial symptom 
scales all loaded onto a higher order factor of general distress with loadings ranging from 0.38 
(appetite loss) to 0.76 (social anxiety). Dysphoria had loading of 0.91. These 11 factors accounted for 
92% of the variance in the data. All IDAS scales correlated significantly with the EPDS and with 
clinician ratings on the Hamilton Rating Scale for Depression (Watson et al., 2007). Internal 
consistency ranged from 0.74 (suicidality) to 0.91 (general depression). The IDAS remains to be 
validated against a clinical interview in perinatal populations but has shown strong correlations in a 
psychiatric sample particularly between SCID diagnoses of panic disorder and IDAS Panic, 
posttraumatic stress disorder and IDAS Traumatic Intrusions, and social anxiety disorder and IDAS 
Social Anxiety (Watson et al., 2008). However, GAD correlated most strongly with IDAS General 
Depression and Dysphoria, and OCD diagnoses did not show differentially high correlations with any 
IDAS subscales.  
Secondly, an unnamed measure was constructed through an internet survey of 142 questions derived 
from case descriptions of postnatal psychiatric disturbance and DSM-IV-R, with participants asked to 
retrospectively rate the frequency with which they experienced symptoms in the first 30 days after 
birth (Marrs et al., 2009). This measure was not intended for screening purposes but provides 
evidence from factor analysis for broadening the conceptualisation of postnatal distress. Exploratory 
factor analysis yielded 10 factors accounting for 58% of the variance: a general mental status factor 
(28% of the variance), psychoticism / morbid thoughts (6%), generalized anxiety (6%), panic (3%), 
guilt/self-criticism (3%), compulsive behaviour (3%), hyper-vigilance (2%), contentment (2%), 
negative body image (2%) and manic behaviour (2%) (Marrs et al., 2009). Depressive symptoms did 
not load clearly onto one factor and were not the most commonly endorsed items. Internal consistency 
ranged from 0.67 (manic behaviour) to 0.92 (mental status). Forty-three percent of the sample had a 
previous mental health diagnosis and thus the factor structure may differ in more representative 
perinatal samples. The mental status factor captures some of the core emotional and cognitive features 
of anxiety and depression that are similar to the dsyphoria scale on the IDAS. This may indicate that 
perinatal distress is better conceptualised by an underlying factor of general distress onto which 




This systematic review highlights the paucity of research validating measures of anxiety in perinatal 
populations and the heterogeneity of studies that do. It also raises important issues concerning the 
choice of anxiety screening measure to use in perinatal populations. Given the limited data, 
recommendations for each of the measures reviewed are cautiously provided followed by key issues 
that have arisen from this review. 
The limited number of studies validating the HADS-A makes it difficult to draw conclusions about 
the use of this measure in pregnant samples. Despite excellent sensitivity and specificity, low internal 
consistency and discrepancies in factor structure and the prevalence of probable anxiety disorder 
identified using the recommended cut-off of 8 are a concern, although these may be due to cultural or 
methodological differences. Therefore more research is required to validate the HADS-A in perinatal 
samples before it is possible to recommend use of this measure.  
The STAI has demonstrated good criterion validity in pregnant samples although positive predictive 
value was low, which is an issue if the measure is to be used for screening. The six-item version may 
be as useful as the longer version for screening in pregnancy. In the postpartum period, discriminant 
validity has been demonstrated but more research is needed to demonstrate criterion validity. Factor 
analysis is also necessary in pregnant and postpartum samples. The overlap with depressive symptoms 
must be kept in mind when using the STAI. The STAI is the only measure that separates state from 
trait anxiety. More research is needed to investigate stability of the trait scale over time.  
The GHQ may be suitable as a screen for general psychopathology in perinatal populations, with the 
GHQ-12 or the modified GHQ-30 offering the best sensitivity and specificity. Only the GHQ-28 can 
offer a specific measure of anxiety and further factor analysis is required to determine the factor 
structure in perinatal populations. Results from different scoring methods are mixed. If different 
scoring methods result in different probable cases, the clinician or researcher cannot be confident that 
the measure accurately identifies women experiencing distress and in need of further assistance 
(Jomeen and Martin, 2004; Swallow et al., 2003).  
Concerning other measures, the limited evidence suggests that the DSSI/sAD is not appropriate for 
use in perinatal populations in its current form. More research is needed before recommending the use 
of the SCL-90 and HSCL-25 in perinatal populations. The use of a single item ‘Do you feel very 
anxious?’ (Sagrestano et al., 2001) reflects the current guidelines for screening for postnatal 
depression but is unlikely to encompass enough information to successfully screen for different types 
of anxiety disorder and symptoms. The Pregnancy Anxiety Scale (Levin, 1991) may be useful in this 
specific population but studies are needed to validate it as none have been done since its creation. The 
K10 may be of similar use to the GHQ-12 with the benefit of showing further power to discriminate 
anxiety from general distress. The IDAS could be a useful measure in perinatal populations due to the 
inclusion of detailed scales of symptoms of anxiety disorders and depression in the same measure. It 
has shown a clear factor structure in multiple samples but needs to be validated against a clinical 
interview in perinatal samples.  
The DASS-21 has the apparent advantage of differentiating between diagnoses of anxiety, depression 
and stress and it is largely free of somatic items. The DASS remains to be validated against a clinical 
interview in perinatal samples, although research in non-perinatal samples has shown that DASS and 
DASS-21 scores discriminated between diagnoses of major depressive disorder, panic disorder, social 
anxiety disorder , obsessive compulsive disorder and specific phobia; and there is a clear three-factor 
structure with items loading onto the expected factors (Antony et al., 1998). 
A key issue arising from this review is the lack of measures of anxiety specific to pregnant or 
postnatal women. To date, only one anxiety measure has been published that is specific to this 
population (the Pregnancy Anxiety Scale). No measures have been designed for use in the 
postpartum. This is in contrast to postnatal depression where a range of specific measures have been 
developed, such as the EPDS and the Postpartum Depression Screening Scale. This has not been so 
with measures of anxiety despite the overlap of physiological symptoms of anxiety and physiological 
symptoms occurring in pregnancy and the postpartum that may need to be disentangled. 
Related to the need for specific measures, content validity of general measures has not been evidenced 
as many measures contain items that may not be appropriate to perinatal populations. In early 
pregnancy many symptoms (e.g. nausea, vomiting, aches, dizziness) may lead to inflated scores on 
measures that include somatic symptoms - leading to a higher number of false positives (Swallow et 
al., 2003). The high number of ‘cases’ of women identified by the GHQ supports this position. 
Physical symptoms in the postpartum are also likely to inflate scores, although women may feel such 
symptoms are acceptable and they do not contribute to psychological disorder. Inclusion of somatic 
symptoms is also likely to result in a different factor structure in data from perinatal populations and 
subscale scores may thus not be valid. Care must be taken to ensure that factor structure is determined 
in the population of choice before interpreting subscale scores because a subscale that purports to 
measure somatic distress and thus contribute to an overall ill health score may really just reflect the 
normal physical symptoms of pregnancy. 
Thorough validation of measures is also required. Concurrent, discriminant and factorial validity are 
recognised as important components of ensuring a measure is valid but they do not provide a 
complete picture and it is important that measures are validated against a clinical interview when they 
are being used in a new population. The GHQ12, 28 and 30, STAI, and K-10 have been validated 
against a clinical interview in perinatal samples, but all other measures included remain to be 
validated in this way. Measures also need to be validated in pregnancy and in the postpartum if they 
are to be used in both populations. Only four studies validated measures against a gold standard in the 
postpartum. If the purpose of a measure is to screen for anxiety and indicate those women who need 
further consultation, it is vital to know that it can detect as many true cases as possible as evidenced 
by sensitivity and positive predictive value, which can only be calculated if the measure has been 
validated against a gold standard. Clinician judgement and use of the gold standard will also have an 
effect on the utility of validity coefficients (Joiner et al., 2005). Only the GHQ had been validated 
enough in perinatal populations to enable comparison of validity coefficients, but not specifically for 
the anxiety subscale of the 28-item version. 
Another issue is whether to use general measures of distress or anxiety specific measures. The 
measurement context will influence this decision. In the research context it may be desirable to use a 
questionnaire that can measure a continuum of anxiety symptoms associated with other variables, 
such as the STAI. However, in clinical practice and large surveys, the general measures included in 
this review (GHQ, SCL-90-R, K10) may offer the best utility in detecting cases of psychiatric 
morbidity.  However these measures will not offer as much information about the experience of 
anxiety as a specific anxiety measure.   
Additionally, general anxiety measures that have not been designed for the perinatal period may miss 
facets of anxiety that are particular to this period. The Pregnancy Anxiety Scale (Levin, 1991) 
measures anxiety related to pregnancy, anxiety related to childbirth, and anxiety related to 
hospitalization.  A number of measures have been developed that are specific to pregnancy and 
consider aspects related to anxiety such as worry or daily hassles but do not measure anxiety itself 
(Cambridge Worry Scale: Green et al., 2003; Pregnancy Experience Scale: DiPietro et al., 2004). 
These measures are not designed for the postpartum. Furthermore some women may be more prone to 
developing anxiety as consequence of specific physiological and psychological processes associated 
with birth which raise additional considerations for measurement (Heron et al., 2004). Further 
research and meta-analyses of prevalence of anxiety disorders in perinatal populations will assist in 
determining which anxiety disorders pose particular problems for perinatal populations.   
A key issue arising from this review is the overlap of depression and anxiety symptoms in the 
perinatal period and how to differentiate them. Concurrent validity will only yield useful information 
in as much as the reference measure (or clinical interview) measures that which it purports to 
measure. Self-report measures of a construct should correlate more highly with another measure of the 
same construct, than with a purported measure of a different construct (Watson et al., 2008, Clark and 
Watson, 1991). For example, the EPDS is used as a measure of depression but  evidence suggests a 
few items on the EPDS measure anxiety (Phillips et al., 2009; Jomeen and Martin, 2005). Thus one 
cannot know whether the measure being validated is correlating with anxiety or depression symptoms. 
In this review, both the HADS-A  and the state scale of the STAI correlated more highly with the 
EPDS than with other measures of depression supporting the evidence that the EPDS does detect 
anxiety but obscuring the extent to which the STAI and HADS-A are specific to anxiety or share 
overlap with symptoms of depression in perinatal samples.  
More generally, the case for broadening the measurement of postnatal distress has been put forward 
(Heron et al., 2004; Miller et al., 2006; Ross et al., 2003). This has begun to be captured in 
development of measures. The IDAS, although a general symptom measure, shows evidence of a 
general distress scale underlying factors of anxiety and depression. This may be useful in capturing 
the close relationship between depression and anxiety in the perinatal period. The DASS-21 is also of 
interest in perinatal populations due its separation of anxiety, stress and depression and exclusion of 
somatic factors. Both of these measures have the advantage of encompassing a broader concept of 
postnatal distress. 
Researchers and clinicians will need to determine the best measure for their particular needs in 
screening or researching anxiety in pregnancy or the postpartum, although some tentative conclusions 
can be drawn. The STAI is a robust and specific measure of anxiety that has been validated against 
clinical interview and shows discriminant and predictive validity in perinatal samples and may 
therefore be most useful for research purposes. The K10 may be the best short screening measure due 
to its ability, over the GHQ-12, to differentiate anxiety disorders. The DASS-21 shows appropriate 
content and a logical next step is to validate it against clinical interview. The DASS-21 and IDAS 
may be most useful for measuring specific but multiple types of distress in pregnancy and the 
postpartum. 
Whilst some recommendations have been made about measures that are suitable for measuring 
perinatal anxiety, this review is limited by the small number of studies that have validated self-report 
measures of anxiety in perinatal populations. Studies vary widely on validation methods and sampling 
so are not easily comparable. Data is mixed for all measures of anxiety which may be due to 
methodological or cultural differences. The review may also be limited by the inclusion of studies in 
English only, and papers may have been missed due to the search strategy. A review of all measures 
of anxiety used at particular perinatal times (as opposed to studies validating self-report measures) 
would provide useful normative data for researchers. Perinatal anxiety is an increasingly recognised 
concern which will need brief, feasible and accurate self-report measures to assist research and 
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Table 1. Overview of studies reviewed 











Abiodun et al., 1993a 1 Nigeria 240 PC Antenatal 
  28.8% 1st trimester 
  33.3% 2nd trimester 








Criterion: Sens, Spec, MR  - 9 
Abiodun, 1994a 2 Nigeria 240 PC Antenatal 
  28.8% 1st trimester 
  33.3% 2nd trimester 








Criterion: Sens, Spec, MR - 6 
Aderibigbe et al.,  
1996b 
3 Nigeria 277 PC Antenatal  
  Late 2nd- early 3rd         





Factorial - 9 
Aderibigbe &  
Gureje, 1992b 
4 Nigeria 277 PC Antenatal 
  Late 2nd –early 3rd  





Criterion: Sens, Spec, MR, 
PPV, NPV 
Concurrent 






Barnett & Parker,  
1985c 
5 Australia 147 PC Postnatal 
i. 3-4 days 












semi structured  
Discriminant - 8 
Barnett & Parker, 
1986c 
6 Australia 147 PC Postnatal 
i. 3-4 days  













Cox et al., 1983 7 UK 230 PC Ante- and postnatal 
i. 12 weeks gestation 
ii.23 weeks gestation 
iii. 1 week postnatal 















Grant et al., 2008 8 Australia 100 R Ante- and postnatal 
i.3rd trimester 














Hundley et al., 1998 9 UK 217 PC Ante- and postnatal 
i.34 weeks gestation 
ii.10 days postnatal 
 
STAI - - Test-retest 
(Trait scale) 
4 
Jomeen & Martin, 
2004 
10 UK 101 PC Antenatal 








  trimester 
 
EPDS 
Kaaya et al., 2002 11 Tanzania 903 R Antenatal 
  8-26 weeks 
  gestation 

















100 PC Antenatal 
  i.12 weeks gestation 
  ii. 34 weeks gestation 
 




Kitamura et al., 
1989d 
 
13 Japan 108 PC Antenatal 










Kitamura et al., 
1993d 
 
14 Japan 108 PC Antenatal 
  <12 weeks gestation 
GHQ-30 - Compared 4 different scoring 




Kitamura et al., 
1994ad 
 
15 Japan 108 PC Ante- and postnatal 
  i.1st trimester 




Criterion: Sens, spec at 4 time 
points 
- 9 
  iii.5 days postnatal 
  iv. 1 month postnatal 
 
Kitamura et al., 
1994bd 
 
16 Japan 108 PC Antenatal 
  i.1st trimester 





Criterion: Sens, Spec, MR, 
PPV, NPV 
- 9 
Levin, 1991 17 USA 266 PC Postnatal measurement 
of antenatal anxiety 
  i.After birth whilst 





- Factorial - 9 
Marrs et al., 2009 18 USA 215 Internet Postnatal 




- Factorial Internal 
consistency 
7 
Marteau & Bekker, 
1992 
19 UK 200 PC Pregnancy STAI (state) 
20, 4, 6 item 
versions 
 
- Concurrent Internal 
consistency 
5 
Martin & Jomeen, 
2003 
20 UK 56 R Ante- and postnatal 
  i.Admission to   
GHQ-12 - Compared 3 different scoring 




hospital for birth 
  ii. Labour 
  iii. 28 day postnatal 
 
Discriminant 
Miller et al., 2006 21 Australia 325 R Postnatal 






- Concurrent Internal 
consistency 
8 
Muzik et al., 2000 22 Austria 50 R Postnatal 









Discriminant - 4 
Navarro et al., 2007 23 Spain 145
3 
PC Postnatal 












Nott & Cutts, 1982 24 UK 212 PC Postnatal 
  8-14 weeks 





Sagrestano et al., 
2001 
25 USA 166 PC Antenatal 











Sharp, 1988 26 UK 179 PC Antenatal 
  <20 weeks gestation 
 
GHQ-30 CIS Criterion: Sens, spec, MR, 
PPV 
- 9 
Spies et al., 2001 27 South 
Africa 
129 PC Antenatal 





Criterion: Sens, spec, LR+, 
LR-, PPV, NPV 
- 9 
Stuart et al., 1998 28 USA 107 C Postnatal 
  i. 14 weeks 







- Concurrent - 9 
Swallow et al., 2003 29 UK 273 PC Antenatal 
  10-13 weeks  
  Gestation 
GHQ-28 - Compared 2 different scoring 




 Watson et al., 2007 30 USA 830 C Postnatal 











Notes: The same alphabet letter in superscript represents the same sample. 
 
Sample:PC = primary care e.g. women at antenatal clinic; R = subsample of a research study; C = community 
 
Self-report instruments: CC-D&A = Trait anxiety & depression scales (Costello & Comrey, 1967); BAI = Beck Anxiety Inventory (Beck & Steer, 1991); BDI = Beck 
Depression Inventory (Beck, 1961); ENES = Eysenck Neuroticism & Extroversion Scale (Eysenck & Eysenck, 1964); ISSI = Interview Schedule for Social Interaction 
(Henderson, 1981); HSPA = Hereford Scale of Parental Attitudes (Hereford, 1963); LES = Life Event Schedule (Barnett et al, 1983); DSSI/sAD = State of Anxiety and 
Depression (Bedford & Foulds, 1978); STAI = State Trait Anxiety Inventory (Spielberger, 1983); HADS = Hospital Anxiety and Depression Scale (Zigmond & Snaith, 
1983); EPDS = Edinburgh Postnatal Depression Scale (Cox, Holden & Sagovsky, 1987); GHQ = General Health Questionnaire; DASS-21 = Depression Anxiety Stress 
Scales (Lovibond & Lovibond, 1995); SCL-90-R = Symptom Checklist 90 Revised (Derogatis, 1992); Zung SRDS = Zung self-rating depression scale (Zung, 1965);PSAI = 
Perinatal Self-Administered Inventory (clinic devised); Conflict Tactics Scale (Straus, 1979); CES-D = Centre for Epidemiological Studies Depression Scale (Radloff, 1977); 
PSS = Perceived Stress Scale (Cohen, Kamarck & Mermelstein, 1983);  K-10 = Kessler 10 (Kessler et al., 2002); IDAS = Inventory of Depression and Anxiety Symptoms 
(Watson et al., 2007) 
 
Interview and diagnostic criteria: ICD-9 = International classification of diseases; DSM = Diagnostic and Statistical Manual of Mental Disorders; SCID = Structured 
Clinical Interview for DSM; SADS = Schedule for Affective Disorders and Schizophrenia (Spitzer & Endicott, 1978); RDC = Research Diagnostic Criteria; CIS = Clinical 
Interview Schedule (Goldberg et al., 1970); HRSD = Hamilton Rating Scale for Depression (Hamilton, 1960); PSE = Present State Examination (Wing et al., 1974); PAS = 
Psychiatric Assessment Schedule; SPI = Standardised Psychiatric Interview. 
 
Validity: Sens = sensitivity; Spec = specificity; MR = misclassification rate; PPV = positive predictive value; NPV = negative predictive value; NND = number needed to 













Table 2. Obtained norms for the State-Trait Anxiety Inventory  
Study  
Time of measurement 
 Population M (SD) 
  State Trait 
Barnett and Parker, 1985a    
< 3 weeks postpartum High anxiety 41.2 45.1 
 Moderate anxiety 32.2 32.4 
 Low anxiety 24.9 23.0 
    
    
Grant et al.,  2008    
3rd trimester of pregnancy Antenatal diagnosed anxiety disorder 48.38 (11.33) 52.10 (10.63) 
 Antenatal no diagnosis 32.70 (9.25) 33.57 (10.09) 
    
32 weeks postpartum Postnatal diagnosed anxiety disorder 45.72 (12.26) 47.17 (10.76) 
 Postnatal no diagnosis 33.32 (8.73) 33.24 (8.64) 
    
    
    
Marteau and Bekker, 
1992 
   
Pregnancy  Pregnant women, full form (20 items) 37.6 (9.1) - 
 Pregnant women, prorated from 6 items 37.1 (11.0) - 
 Pregnant women, prorated from 4 items 38.4 (12.0) - 
    
 Pregnant women, abnormal screen, full-form 46.4 (14.8) - 
  Pregnant women, abnormal screen, 6 items 47.7 (15.8) - 
 Pregnant women, abnormal screen, 4 items - - 
    
Stuart et al., 1998    
14 weeks postpartum Postpartum women 30.43 (10.34) 33.21 (10.03) 
30 weeks postpartum Postpartum women 31.17 (9.91) 33.02 (9.45) 
    
    
    
    
    
aSubjects were allocated to groups of high, moderate or low anxiety according to self-report scores on the STAI: ≥40 =high 
























Table 3. GHQ validity coefficients and norms 
Version 





















       
GHQ -12       
 (Abiodun, 1994)  3 83.3 81.4 - - 18.3 
 (Navarro et al., 
1997) 
4/5 80.6 80.4 1.6 b - - 
       
GHQ-28       
 (Aderibigbe & 
Gureje, 1992) 
      
   GHQ scoring 3/4 75 83    46 95 18 
   C-GHQ scoring 7/8 82 85 53 96 16 
       
GHQ-30       
 (Abiodun, 1993) 5 80 80.9 - - 19.1 
 (Kitamura et al.) 
(year) 
      
     1st trimester 
(1989) 
7/8 83.3 71.1 37 96 26.9 
     3rd trimester 
(1994b) 
 38.5 82.4 25 90 - 
     1st day postnatal 
(1994a) 
 27.8 79.2 - - - 
54 
 
     5th month 
postnatal (1994a) 
 50.0 84.3 - - - 
        
 (Nott & Cutts, 
1982) 
      
     Unmodified 6/7 80 89 50 97 19 
     Author modified 6/7 83 87 53 96 16 
       
 (Sharp, 1988)a 5/6 77 78 52 96 22 
 
Note: aClinical Interview Schedule cut-off point of 17/18; bSampling strategy prohibited calculation of positive 
predictive value, therefore the authors reported number needed to diagnose, a function of specificity and 
sensitivity which is stable across populations.  
 
 
 
 
 
 
